Kevin Rosenbach, MD
Allergy & Immunology · Naples, FLNPI 1841268133
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by ADMA Biomanufacturing LLC at 26.2% of the total. Among allergy & immunology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 571 payments — averaging $247.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ADMA Biomanufacturing LLC$37K
- Shire North American Group Inc$31K
- Takeda Pharmaceuticals U.S.A., Inc.$28K
- Grifols USA, LLC$21K
- Pfizer$9K
- Catalyst Pharmaceuticals, Inc.$4K
- plus $12K from 29 others
What the payments were for
- Consulting fees$25,10018%
- Speaking & faculty fees$77,55655%
- Travel & lodging$23,15016%
- Food & beverage$15,53911%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ADMA Biomanufacturing LLC | 67 | $37,029 |
| Shire North American Group Inc | 67 | $31,265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 121 | $27,644 |
| Grifols USA, LLC | 33 | $20,907 |
| Pfizer | 52 | $8,742 |
| Catalyst Pharmaceuticals, Inc. | 17 | $3,890 |
| CSL Behring | 32 | $2,373 |
| Genentech USA, Inc. | 19 | $1,994 |
| Octapharma USA, Inc. | 23 | $1,740 |
| Blueprint Medicines Corporation | 4 | $1,403 |
| Pharming Healthcare, Inc. | 16 | $705 |
| AstraZeneca | 20 | $511 |
| Novartis | 12 | $466 |
| GSK | 19 | $370 |
| Amgen(2 entities) | 9 | $340 |
| Bio Products Laboratory USA, Inc. | 1 | $336 |
| Sanofi | 9 | $257 |
| Grifols Shared Services North America, Inc. | 3 | $228 |
| Regeneron Healthcare Solutions, Inc. | 7 | $194 |
| Kaleo, Inc. | 10 | $170 |
| Gilead | 9 | $145 |
| Regeneron | 1 | $121 |
| GC Biopharma USA, Inc. | 3 | $118 |
| Circassia Inc. | 2 | $92 |
| Argenx US, Inc. | 2 | $59 |
| Alk-abello, Inc | 4 | $54 |
| Ionis Pharmaceuticals, Inc. | 1 | $39 |
| Lilly USA, LLC | 1 | $34 |
| X4 Pharmaceuticals, Inc. | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Merck | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Optinose US, Inc. | 1 | $15 |
| Insmed, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$141,355 in reported general payments places this provider in the 90th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 49 | $543,807 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 45 | $422,969 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 13 | $300,947 |
| CutaquigImmun Glob G(Igg)-Hipp/Maltose | 13 | $168,005 |
| CibinqoAbrocitinib | 12 | $69,346 |
| Epinephrine | 49 | $13,013 |
| Cromolyn Sodium | 19 | $8,972 |
| Cevimeline Hcl | 16 | $5,662 |
| Fluconazole | 138 | $5,574 |
| Oseltamivir Phosphate | 192 | $4,659 |
| ValacyclovirValacyclovir Hcl | 54 | $3,517 |
| Hydroxychloroquine Sulfate | 22 | $953 |
| Ipratropium Bromide | 18 | $711 |
| Colchicine | 11 | $679 |
| Azithromycin | 34 | $662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $27,644 | $543,80749 claims |
| Grifols USA, LLCGamunex-C | $20,907 | $422,96945 claims |
| Octapharma USA, Inc.Cutaquig | $1,740 | $168,00513 claims |
| PfizerCibinqo | $8,742 | $69,34612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Naples
- Florina NeaguNaples$16K
- Dennis LedfordTampa$1.2M
- Nina RamirezMiami$833K
- Thomas WestbrookPensacola$810K
- Shahnaz FattehPlantation$677K
- Thomas CasaleTampa$382K
- Thomas JohnsonGainesville$361K
- Mark GlaumTampa$337K
- Alan HalseyValrico$243K
- Steve DormanJacksonville$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.